NCT02182739已完成不适用
Programa de Experiencia Therapéutica Personalizada (Personalized Therapeutic Experience Program)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 13,039
- 主要终点
- Change in assessment of intensity of pain on a 4-point verbal rating scale
研究概览
简要总结
Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients according to the physicians medical criteria on the labeled indications for Meloxicam
排除标准
- 未提供
研究组 & 干预措施
Meloxicam
干预措施: Meloxicam (Drug)
结局指标
主要结局
Change in assessment of intensity of pain on a 4-point verbal rating scale
时间窗: up to 1 year
Assessment of tolerability on a 4-point scale
时间窗: up to 1 year
次要结局
- Number of patients with adverse events(up to 1 year)
研究者
相似试验
招募中
不适用
Implementation of the Specific Treatment Of Problems of the Spine Approach in BangladeshChronic Low-back PainNCT05880212Mohammad Ali154
招募中
不适用
Evaluating the Treatment in the MZEB AachenDisability PhysicalIntellectual DisabilityNCT04781452RWTH Aachen University2,000
尚未招募
不适用
Levels of Diagnostic and Therapeutic Intervention in Hospitalized PatientsAcute DiseaseNCT06315842Consorci Sanitari de l'Alt Penedès i Garraf20
已完成
不适用
Optimizing PharmacoTherapy In the Multimorbid Elderly in Primary CAre: the OPTICA TrialMultimorbidityPolypharmacyNCT03724539University of Bern323
已完成
不适用
Evaluation of a Patient-Reported Symptom Index for NMIBCSuperficial Bladder CancerNCT03091764University of Sydney498